Qureight Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 58

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $20.1M

  • Investors
  • 12

Qureight General Information

Description

Developer of a clinical data curation and analytics platform designed to combine technology and life sciences to accelerate drug development. The company's platform leverages artificial intelligence (AI) to explore large clinical datasets in collaboration with hospitals, pharmaceutical companies, and software developers to assist in structuring images and paired clinical metadata in complex diseases, enabling health practitioners to identify novel biomarkers and understand diseases and therapeutic approaches.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 50 - 60 Station Road
  • Cambridge CB1 2JH
  • England, United Kingdom
+44 01223
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 50 - 60 Station Road
  • Cambridge CB1 2JH
  • England, United Kingdom
+44 01223

Qureight Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qureight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 29-Jul-2026 $20.1M Completed Generating Revenue
4. Later Stage VC (Series A) 16-Apr-2024 Completed Generating Revenue
3. Seed Round 02-Feb-2022 Completed Generating Revenue
2. Seed Round 14-Sep-2020 $687K $687K Completed Generating Revenue
1. Accelerator/Incubator 04-Jan-2018 Completed Startup
To view Qureight’s complete valuation and funding history, request access »

Qureight Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C2 Ordinary
C1 Ordinary
C1 Ordinary
B Ordinary
B Ordinary
B Ordinary
A Ordinary 3,614,000 $0.000134 $0.57 $0.57 1x $0.57 9.82%
Seed 2,710,000 $0.000134 $0.26 $0.26 1x $0.26 7.36%
To view Qureight’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Qureight Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical data curation and analytics platform designed to combine technology and life sciences to acceler
Other Healthcare Services
Cambridge, United Kingdom
58 As of 2026

Minnetonka, MN
 

Burlingame, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qureight Competitors (33)

One of Qureight’s 33 competitors is MedNet (Healthcare Technology Systems), a Formerly VC-backed company based in Minnetonka, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MedNet (Healthcare Technology Systems) Formerly VC-backed Minnetonka, MN
Clinovo Formerly VC-backed Burlingame, CA
MMS Holdings Private Equity-Backed Canton, MI
uMotif Venture Capital-Backed London, United Kingdom
YPrime Private Equity-Backed Malvern, PA
You’re viewing 5 of 33 competitors. Get the full list »

Qureight Patents

Qureight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202317160-D0 Quantification of lung Active 09-Nov-2023
GB-2628455-A Quantification of lung fibrosis Active 09-Nov-2023
GB-2628455-B Quantification of lung fibrosis Active 09-Nov-2023
US-20250157664-A1 Quantification of lung fibrosis Pending 09-Nov-2023
GB-202109706-D0 Airway model for assessing lung disease progression Inactive 05-Jul-2021 G06T7/0012
To view Qureight’s complete patent history, request access »

Qureight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qureight Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Molten Ventures Venture Capital Minority
Guinness Ventures Venture Capital Minority
Hargreave Hale AIM VCT 2 Corporation Minority
XTX Ventures Corporate Venture Capital Minority
Cambridge Angels Angel Group Minority
You’re viewing 5 of 12 investors. Get the full list »

Qureight FAQs

  • When was Qureight founded?

    Qureight was founded in 2018.

  • Where is Qureight headquartered?

    Qureight is headquartered in Cambridge, United Kingdom.

  • What is the size of Qureight?

    Qureight has 58 total employees.

  • What industry is Qureight in?

    Qureight’s primary industry is Other Healthcare Services.

  • Is Qureight a private or public company?

    Qureight is a Private company.

  • What is the current valuation of Qureight?

    The current valuation of Qureight is .

  • What is Qureight’s current revenue?

    The current revenue for Qureight is .

  • How much funding has Qureight raised over time?

    Qureight has raised $31.4M.

  • Who are Qureight’s investors?

    Molten Ventures, Guinness Ventures, Hargreave Hale AIM VCT 2, XTX Ventures, and Cambridge Angels are 5 of 12 investors who have invested in Qureight.

  • Who are Qureight’s competitors?

    MedNet (Healthcare Technology Systems), Clinovo, MMS Holdings, uMotif, and YPrime are some of the 33 competitors of Qureight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process